GlassScriptPhysician profile
Brian Jeffrey Peerless
NPI 1962484758
$5,535.38
in general payments reported to CMS, 2019-2025
43 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,268 · 2020: $290 · 2021: $119 · 2022: $664 · 2023: $1,584 · 2024: $375 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,194.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $693.99 | 2019-2023 | |
| Novo Nordisk INC | $504.57 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $466.33 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $342.95 | 2019-2023 | Farxiga |
| Pfizer INC. | $317.54 | 2019-2023 | |
| Lilly USA, LLC | $278.57 | 2019-2024 | Jardiance, Mounjaro, Reyvow |
| Supernus Pharmaceuticals, INC. | $258.68 | 2019-2023 | Qelbree |
| Amgen INC. | $251.53 | 2019-2023 | Otezla, Repatha, Prolia |
| Exact Sciences Corporation | $250.21 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $199.88 | 2019-2020 | |
| Dexcom, INC. | $181.77 | 2023-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $162.10 | 2019-2023 | Trintellix |
| Merck Sharp & Dohme LLC | $154.77 | 2019-2023 | Vaxneuvance, Gardasil 9 |
| Janssen Pharmaceuticals, INC | $148.09 | 2019-2022 | |
| Astellas Pharma US INC | $128.22 | 2020-2023 | Veozah, Myrbetriq |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Peerless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.